AI assistant
ARGAN INC — Director's Dealing 2020
Jan 8, 2020
31210_dirs_2020-01-08_140a2c15-9729-4c55-a372-4d2bf9d4ff31.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARGAN INC (AGX)
CIK: 0000100591
Period of Report: 2019-10-15
Reporting Person: Sherras Brian R (Former Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 27965 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options to purchase Common Stock | $ | Common Stock (35000) | 35000 | Direct |
Footnotes
F1: Electrigen Limited ("Electrigen") acquired the common stock of the Issuer in exchange for Electrigen's ownership interest in Atlantic Projects Company Limited having an estimated value of $917,531.65. The Reporting Person is 50% owner and director of Electrigen; therefore, the Reporting Person may be deemed to indirectly beneficially own the shares owned by Electrigen.
F2: As of the date of this filing, the total number of stock options owned by the Reporting Person includes options to acquire an aggregate number of 35,000 shares of the Issuer's common stock as follows: 1) options to purchase 5,000 shares awarded on 4/2/12 at an exercise price per share of $16.47; 2) options to purchase 10,000 shares awarded on 12/18/12 at an exercise price per share of $18.87; 3) options to purchase 10,000 shares awarded on 12/17/13 at an exercise price per share of $26.88; and 4) options to purchase 10,000 shares awarded on 12/11/14 at an exercise price per share of $31.82. Each set of options became exercisable on the first anniversary of the corresponding award date. All of these stock options will expire on 10/15/20.